img

Global Vials for COVID-19 Vaccine Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Packaging

Publisher : MRA | Format : PDF

Global Vials for COVID-19 Vaccine Market Insights, Forecast to 2034

The global Vials for COVID-19 Vaccine market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Vials for COVID-19 Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Vials for COVID-19 Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Vials for COVID-19 Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Vials for COVID-19 Vaccine include Corning, Schott AG, SiO2 Materials Science, SGD Pharma, Stevanato Group, DWK Life Sciences and Gerresheimer, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes


This report presents an overview of global market for Vials for COVID-19 Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Vials for COVID-19 Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Vials for COVID-19 Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Vials for COVID-19 Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Vials for COVID-19 Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Vials for COVID-19 Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Corning, Schott AG, SiO2 Materials Science, SGD Pharma, Stevanato Group, DWK Life Sciences and Gerresheimer, etc.



By Company


Corning
Schott AG
SiO2 Materials Science
SGD Pharma
Stevanato Group
DWK Life Sciences
Gerresheimer
Segment by Type
Middle-borate Borosilicate Glass
Low-borate Borosilicate Glass

Segment by Application


Vaccine Manufacturing
Vaccine Researching

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Vials for COVID-19 Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3Detailed analysis of Vials for COVID-19 Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8China by type, by application sales and revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vials for COVID-19 Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Study Coverage
1.1 Vials for COVID-19 Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Vials for COVID-19 Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Middle-borate Borosilicate Glass
1.2.3 Low-borate Borosilicate Glass
1.3 Market by Application
1.3.1 Global Vials for COVID-19 Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Vaccine Manufacturing
1.3.3 Vaccine Researching
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Vials for COVID-19 Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Vials for COVID-19 Vaccine Revenue by Region
2.2.1 Global Vials for COVID-19 Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Vials for COVID-19 Vaccine Revenue by Region (2018-2023)
2.2.3 Global Vials for COVID-19 Vaccine Revenue by Region (2024-2029)
2.2.4 Global Vials for COVID-19 Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Vials for COVID-19 Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Vials for COVID-19 Vaccine Sales by Region
2.4.1 Global Vials for COVID-19 Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Vials for COVID-19 Vaccine Sales by Region (2018-2023)
2.4.3 Global Vials for COVID-19 Vaccine Sales by Region (2024-2029)
2.4.4 Global Vials for COVID-19 Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Vials for COVID-19 Vaccine Sales by Manufacturers
3.1.1 Global Vials for COVID-19 Vaccine Sales by Manufacturers (2018-2023)
3.1.2 Global Vials for COVID-19 Vaccine Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vials for COVID-19 Vaccine in 2022
3.2 Global Vials for COVID-19 Vaccine Revenue by Manufacturers
3.2.1 Global Vials for COVID-19 Vaccine Revenue by Manufacturers (2018-2023)
3.2.2 Global Vials for COVID-19 Vaccine Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Vials for COVID-19 Vaccine Revenue in 2022
3.3 Global Key Players of Vials for COVID-19 Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Vials for COVID-19 Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Vials for COVID-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Vials for COVID-19 Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Vials for COVID-19 Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Vials for COVID-19 Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vials for COVID-19 Vaccine Sales by Type
4.1.1 Global Vials for COVID-19 Vaccine Historical Sales by Type (2018-2023)
4.1.2 Global Vials for COVID-19 Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Vials for COVID-19 Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Vials for COVID-19 Vaccine Revenue by Type
4.2.1 Global Vials for COVID-19 Vaccine Historical Revenue by Type (2018-2023)
4.2.2 Global Vials for COVID-19 Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Vials for COVID-19 Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Vials for COVID-19 Vaccine Price by Type
4.3.1 Global Vials for COVID-19 Vaccine Price by Type (2018-2023)
4.3.2 Global Vials for COVID-19 Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Vials for COVID-19 Vaccine Sales by Application
5.1.1 Global Vials for COVID-19 Vaccine Historical Sales by Application (2018-2023)
5.1.2 Global Vials for COVID-19 Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Vials for COVID-19 Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Vials for COVID-19 Vaccine Revenue by Application
5.2.1 Global Vials for COVID-19 Vaccine Historical Revenue by Application (2018-2023)
5.2.2 Global Vials for COVID-19 Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Vials for COVID-19 Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Vials for COVID-19 Vaccine Price by Application
5.3.1 Global Vials for COVID-19 Vaccine Price by Application (2018-2023)
5.3.2 Global Vials for COVID-19 Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Vials for COVID-19 Vaccine Market Size by Type
6.1.1 US & Canada Vials for COVID-19 Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Vials for COVID-19 Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Vials for COVID-19 Vaccine Market Size by Application
6.2.1 US & Canada Vials for COVID-19 Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Vials for COVID-19 Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Vials for COVID-19 Vaccine Market Size by Country
6.3.1 US & Canada Vials for COVID-19 Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Vials for COVID-19 Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Vials for COVID-19 Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Vials for COVID-19 Vaccine Market Size by Type
7.1.1 Europe Vials for COVID-19 Vaccine Sales by Type (2018-2029)
7.1.2 Europe Vials for COVID-19 Vaccine Revenue by Type (2018-2029)
7.2 Europe Vials for COVID-19 Vaccine Market Size by Application
7.2.1 Europe Vials for COVID-19 Vaccine Sales by Application (2018-2029)
7.2.2 Europe Vials for COVID-19 Vaccine Revenue by Application (2018-2029)
7.3 Europe Vials for COVID-19 Vaccine Market Size by Country
7.3.1 Europe Vials for COVID-19 Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Vials for COVID-19 Vaccine Sales by Country (2018-2029)
7.3.3 Europe Vials for COVID-19 Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Vials for COVID-19 Vaccine Market Size
8.1.1 China Vials for COVID-19 Vaccine Sales (2018-2029)
8.1.2 China Vials for COVID-19 Vaccine Revenue (2018-2029)
8.2 China Vials for COVID-19 Vaccine Market Size by Application
8.2.1 China Vials for COVID-19 Vaccine Sales by Application (2018-2029)
8.2.2 China Vials for COVID-19 Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Vials for COVID-19 Vaccine Market Size by Type
9.1.1 Asia Vials for COVID-19 Vaccine Sales by Type (2018-2029)
9.1.2 Asia Vials for COVID-19 Vaccine Revenue by Type (2018-2029)
9.2 Asia Vials for COVID-19 Vaccine Market Size by Application
9.2.1 Asia Vials for COVID-19 Vaccine Sales by Application (2018-2029)
9.2.2 Asia Vials for COVID-19 Vaccine Revenue by Application (2018-2029)
9.3 Asia Vials for COVID-19 Vaccine Sales by Region
9.3.1 Asia Vials for COVID-19 Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Vials for COVID-19 Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Vials for COVID-19 Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Vials for COVID-19 Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Vials for COVID-19 Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Corning
11.1.1 Corning Company Information
11.1.2 Corning Overview
11.1.3 Corning Vials for COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Corning Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Corning Recent Developments
11.2 Schott AG
11.2.1 Schott AG Company Information
11.2.2 Schott AG Overview
11.2.3 Schott AG Vials for COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Schott AG Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Schott AG Recent Developments
11.3 SiO2 Materials Science
11.3.1 SiO2 Materials Science Company Information
11.3.2 SiO2 Materials Science Overview
11.3.3 SiO2 Materials Science Vials for COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 SiO2 Materials Science Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 SiO2 Materials Science Recent Developments
11.4 SGD Pharma
11.4.1 SGD Pharma Company Information
11.4.2 SGD Pharma Overview
11.4.3 SGD Pharma Vials for COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 SGD Pharma Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 SGD Pharma Recent Developments
11.5 Stevanato Group
11.5.1 Stevanato Group Company Information
11.5.2 Stevanato Group Overview
11.5.3 Stevanato Group Vials for COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Stevanato Group Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Stevanato Group Recent Developments
11.6 DWK Life Sciences
11.6.1 DWK Life Sciences Company Information
11.6.2 DWK Life Sciences Overview
11.6.3 DWK Life Sciences Vials for COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 DWK Life Sciences Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 DWK Life Sciences Recent Developments
11.7 Gerresheimer
11.7.1 Gerresheimer Company Information
11.7.2 Gerresheimer Overview
11.7.3 Gerresheimer Vials for COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Gerresheimer Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Gerresheimer Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vials for COVID-19 Vaccine Industry Chain Analysis
12.2 Vials for COVID-19 Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vials for COVID-19 Vaccine Production Mode & Process
12.4 Vials for COVID-19 Vaccine Sales and Marketing
12.4.1 Vials for COVID-19 Vaccine Sales Channels
12.4.2 Vials for COVID-19 Vaccine Distributors
12.5 Vials for COVID-19 Vaccine Customers
13 Market Dynamics
13.1 Vials for COVID-19 Vaccine Industry Trends
13.2 Vials for COVID-19 Vaccine Market Drivers
13.3 Vials for COVID-19 Vaccine Market Challenges
13.4 Vials for COVID-19 Vaccine Market Restraints
14 Key Findings in The Global Vials for COVID-19 Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Vials for COVID-19 Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Middle-borate Borosilicate Glass
Table 3. Major Manufacturers of Low-borate Borosilicate Glass
Table 4. Global Vials for COVID-19 Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Vials for COVID-19 Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Vials for COVID-19 Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Vials for COVID-19 Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Vials for COVID-19 Vaccine Revenue Market Share by Region (2018-2023)
Table 9. Global Vials for COVID-19 Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Vials for COVID-19 Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Vials for COVID-19 Vaccine Sales by Region (2018-2023) & (Million Units)
Table 12. Global Vials for COVID-19 Vaccine Sales by Region (2024-2029) & (Million Units)
Table 13. Global Vials for COVID-19 Vaccine Sales Market Share by Region (2018-2023)
Table 14. Global Vials for COVID-19 Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Vials for COVID-19 Vaccine Sales by Manufacturers (2018-2023) & (Million Units)
Table 16. Global Vials for COVID-19 Vaccine Sales Share by Manufacturers (2018-2023)
Table 17. Global Vials for COVID-19 Vaccine Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Vials for COVID-19 Vaccine Revenue Share by Manufacturers (2018-2023)
Table 19. Global Key Players of Vials for COVID-19 Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 20. Vials for COVID-19 Vaccine Price by Manufacturers 2018-2023 (US$/K Units)
Table 21. Global Vials for COVID-19 Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Vials for COVID-19 Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vials for COVID-19 Vaccine as of 2022)
Table 23. Global Key Manufacturers of Vials for COVID-19 Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Vials for COVID-19 Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Vials for COVID-19 Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Vials for COVID-19 Vaccine Sales by Type (2018-2023) & (Million Units)
Table 28. Global Vials for COVID-19 Vaccine Sales by Type (2024-2029) & (Million Units)
Table 29. Global Vials for COVID-19 Vaccine Sales Share by Type (2018-2023)
Table 30. Global Vials for COVID-19 Vaccine Sales Share by Type (2024-2029)
Table 31. Global Vials for COVID-19 Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Vials for COVID-19 Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Vials for COVID-19 Vaccine Revenue Share by Type (2018-2023)
Table 34. Global Vials for COVID-19 Vaccine Revenue Share by Type (2024-2029)
Table 35. Vials for COVID-19 Vaccine Price by Type (2018-2023) & (US$/K Units)
Table 36. Global Vials for COVID-19 Vaccine Price Forecast by Type (2024-2029) & (US$/K Units)
Table 37. Global Vials for COVID-19 Vaccine Sales by Application (2018-2023) & (Million Units)
Table 38. Global Vials for COVID-19 Vaccine Sales by Application (2024-2029) & (Million Units)
Table 39. Global Vials for COVID-19 Vaccine Sales Share by Application (2018-2023)
Table 40. Global Vials for COVID-19 Vaccine Sales Share by Application (2024-2029)
Table 41. Global Vials for COVID-19 Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Vials for COVID-19 Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Vials for COVID-19 Vaccine Revenue Share by Application (2018-2023)
Table 44. Global Vials for COVID-19 Vaccine Revenue Share by Application (2024-2029)
Table 45. Vials for COVID-19 Vaccine Price by Application (2018-2023) & (US$/K Units)
Table 46. Global Vials for COVID-19 Vaccine Price Forecast by Application (2024-2029) & (US$/K Units)
Table 47. US & Canada Vials for COVID-19 Vaccine Sales by Type (2018-2023) & (Million Units)
Table 48. US & Canada Vials for COVID-19 Vaccine Sales by Type (2024-2029) & (Million Units)
Table 49. US & Canada Vials for COVID-19 Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 50. US & Canada Vials for COVID-19 Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Vials for COVID-19 Vaccine Sales by Application (2018-2023) & (Million Units)
Table 52. US & Canada Vials for COVID-19 Vaccine Sales by Application (2024-2029) & (Million Units)
Table 53. US & Canada Vials for COVID-19 Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 54. US & Canada Vials for COVID-19 Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Vials for COVID-19 Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Vials for COVID-19 Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 57. US & Canada Vials for COVID-19 Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Vials for COVID-19 Vaccine Sales by Country (2018-2023) & (Million Units)
Table 59. US & Canada Vials for COVID-19 Vaccine Sales by Country (2024-2029) & (Million Units)
Table 60. Europe Vials for COVID-19 Vaccine Sales by Type (2018-2023) & (Million Units)
Table 61. Europe Vials for COVID-19 Vaccine Sales by Type (2024-2029) & (Million Units)
Table 62. Europe Vials for COVID-19 Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 63. Europe Vials for COVID-19 Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Vials for COVID-19 Vaccine Sales by Application (2018-2023) & (Million Units)
Table 65. Europe Vials for COVID-19 Vaccine Sales by Application (2024-2029) & (Million Units)
Table 66. Europe Vials for COVID-19 Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 67. Europe Vials for COVID-19 Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Vials for COVID-19 Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Vials for COVID-19 Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 70. Europe Vials for COVID-19 Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Vials for COVID-19 Vaccine Sales by Country (2018-2023) & (Million Units)
Table 72. Europe Vials for COVID-19 Vaccine Sales by Country (2024-2029) & (Million Units)
Table 73. China Vials for COVID-19 Vaccine Sales by Type (2018-2023) & (Million Units)
Table 74. China Vials for COVID-19 Vaccine Sales by Type (2024-2029) & (Million Units)
Table 75. China Vials for COVID-19 Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 76. China Vials for COVID-19 Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Vials for COVID-19 Vaccine Sales by Application (2018-2023) & (Million Units)
Table 78. China Vials for COVID-19 Vaccine Sales by Application (2024-2029) & (Million Units)
Table 79. China Vials for COVID-19 Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 80. China Vials for COVID-19 Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Vials for COVID-19 Vaccine Sales by Type (2018-2023) & (Million Units)
Table 82. Asia Vials for COVID-19 Vaccine Sales by Type (2024-2029) & (Million Units)
Table 83. Asia Vials for COVID-19 Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 84. Asia Vials for COVID-19 Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Vials for COVID-19 Vaccine Sales by Application (2018-2023) & (Million Units)
Table 86. Asia Vials for COVID-19 Vaccine Sales by Application (2024-2029) & (Million Units)
Table 87. Asia Vials for COVID-19 Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 88. Asia Vials for COVID-19 Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Vials for COVID-19 Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Vials for COVID-19 Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 91. Asia Vials for COVID-19 Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Vials for COVID-19 Vaccine Sales by Region (2018-2023) & (Million Units)
Table 93. Asia Vials for COVID-19 Vaccine Sales by Region (2024-2029) & (Million Units)
Table 94. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales by Type (2018-2023) & (Million Units)
Table 95. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales by Type (2024-2029) & (Million Units)
Table 96. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 97. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales by Application (2018-2023) & (Million Units)
Table 99. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales by Application (2024-2029) & (Million Units)
Table 100. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales by Country (2018-2023) & (Million Units)
Table 106. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales by Country (2024-2029) & (Million Units)
Table 107. Corning Company Information
Table 108. Corning Description and Major Businesses
Table 109. Corning Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 110. Corning Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Corning Recent Developments
Table 112. Schott AG Company Information
Table 113. Schott AG Description and Major Businesses
Table 114. Schott AG Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 115. Schott AG Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Schott AG Recent Developments
Table 117. SiO2 Materials Science Company Information
Table 118. SiO2 Materials Science Description and Major Businesses
Table 119. SiO2 Materials Science Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 120. SiO2 Materials Science Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. SiO2 Materials Science Recent Developments
Table 122. SGD Pharma Company Information
Table 123. SGD Pharma Description and Major Businesses
Table 124. SGD Pharma Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 125. SGD Pharma Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. SGD Pharma Recent Developments
Table 127. Stevanato Group Company Information
Table 128. Stevanato Group Description and Major Businesses
Table 129. Stevanato Group Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 130. Stevanato Group Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Stevanato Group Recent Developments
Table 132. DWK Life Sciences Company Information
Table 133. DWK Life Sciences Description and Major Businesses
Table 134. DWK Life Sciences Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 135. DWK Life Sciences Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. DWK Life Sciences Recent Developments
Table 137. Gerresheimer Company Information
Table 138. Gerresheimer Description and Major Businesses
Table 139. Gerresheimer Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 140. Gerresheimer Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Gerresheimer Recent Developments
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Vials for COVID-19 Vaccine Distributors List
Table 145. Vials for COVID-19 Vaccine Customers List
Table 146. Vials for COVID-19 Vaccine Market Trends
Table 147. Vials for COVID-19 Vaccine Market Drivers
Table 148. Vials for COVID-19 Vaccine Market Challenges
Table 149. Vials for COVID-19 Vaccine Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Vials for COVID-19 Vaccine Product Picture
Figure 2. Global Vials for COVID-19 Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Vials for COVID-19 Vaccine Market Share by Type in 2022 & 2029
Figure 4. Middle-borate Borosilicate Glass Product Picture
Figure 5. Low-borate Borosilicate Glass Product Picture
Figure 6. Global Vials for COVID-19 Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Vials for COVID-19 Vaccine Market Share by Application in 2022 & 2029
Figure 8. Vaccine Manufacturing
Figure 9. Vaccine Researching
Figure 10. Vials for COVID-19 Vaccine Report Years Considered
Figure 11. Global Vials for COVID-19 Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Vials for COVID-19 Vaccine Revenue 2018-2029 (US$ Million)
Figure 13. Global Vials for COVID-19 Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Vials for COVID-19 Vaccine Revenue Market Share by Region (2018-2029)
Figure 15. Global Vials for COVID-19 Vaccine Sales 2018-2029 ((Million Units)
Figure 16. Global Vials for COVID-19 Vaccine Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Vials for COVID-19 Vaccine Sales YoY (2018-2029) & (Million Units)
Figure 18. US & Canada Vials for COVID-19 Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Vials for COVID-19 Vaccine Sales YoY (2018-2029) & (Million Units)
Figure 20. Europe Vials for COVID-19 Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Vials for COVID-19 Vaccine Sales YoY (2018-2029) & (Million Units)
Figure 22. China Vials for COVID-19 Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Vials for COVID-19 Vaccine Sales YoY (2018-2029) & (Million Units)
Figure 24. Asia (excluding China) Vials for COVID-19 Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales YoY (2018-2029) & (Million Units)
Figure 26. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Vials for COVID-19 Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Vials for COVID-19 Vaccine in the World: Market Share by Vials for COVID-19 Vaccine Revenue in 2022
Figure 29. Global Vials for COVID-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Vials for COVID-19 Vaccine Sales Market Share by Type (2018-2029)
Figure 31. Global Vials for COVID-19 Vaccine Revenue Market Share by Type (2018-2029)
Figure 32. Global Vials for COVID-19 Vaccine Sales Market Share by Application (2018-2029)
Figure 33. Global Vials for COVID-19 Vaccine Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Vials for COVID-19 Vaccine Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Vials for COVID-19 Vaccine Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Vials for COVID-19 Vaccine Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Vials for COVID-19 Vaccine Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Vials for COVID-19 Vaccine Revenue Share by Country (2018-2029)
Figure 39. US & Canada Vials for COVID-19 Vaccine Sales Share by Country (2018-2029)
Figure 40. U.S. Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Vials for COVID-19 Vaccine Sales Market Share by Type (2018-2029)
Figure 43. Europe Vials for COVID-19 Vaccine Revenue Market Share by Type (2018-2029)
Figure 44. Europe Vials for COVID-19 Vaccine Sales Market Share by Application (2018-2029)
Figure 45. Europe Vials for COVID-19 Vaccine Revenue Market Share by Application (2018-2029)
Figure 46. Europe Vials for COVID-19 Vaccine Revenue Share by Country (2018-2029)
Figure 47. Europe Vials for COVID-19 Vaccine Sales Share by Country (2018-2029)
Figure 48. Germany Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 49. France Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. China Vials for COVID-19 Vaccine Sales Market Share by Type (2018-2029)
Figure 54. China Vials for COVID-19 Vaccine Revenue Market Share by Type (2018-2029)
Figure 55. China Vials for COVID-19 Vaccine Sales Market Share by Application (2018-2029)
Figure 56. China Vials for COVID-19 Vaccine Revenue Market Share by Application (2018-2029)
Figure 57. Asia Vials for COVID-19 Vaccine Sales Market Share by Type (2018-2029)
Figure 58. Asia Vials for COVID-19 Vaccine Revenue Market Share by Type (2018-2029)
Figure 59. Asia Vials for COVID-19 Vaccine Sales Market Share by Application (2018-2029)
Figure 60. Asia Vials for COVID-19 Vaccine Revenue Market Share by Application (2018-2029)
Figure 61. Asia Vials for COVID-19 Vaccine Revenue Share by Region (2018-2029)
Figure 62. Asia Vials for COVID-19 Vaccine Sales Share by Region (2018-2029)
Figure 63. Japan Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. India Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Vials for COVID-19 Vaccine Sales Share by Country (2018-2029)
Figure 74. Brazil Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Vials for COVID-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. Vials for COVID-19 Vaccine Value Chain
Figure 80. Vials for COVID-19 Vaccine Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed